Identification of an immunodominant mouse minor histocompatibility antigen (MiHA): T cell response to a single dominant MiHA causes graft- versus-host disease

Journal of Clinical Investigation

Volumn 98, Issue 3, 1996, Pages 622-628

  Perreault, Claude ^a   Jutras, Julie ^a   Roy, Denis C ^a   Filep, Janos G ^a   Brochu, Sylvie ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

amino acid sequence; antigenic determinant; CD8 positive T lymphocytes; H 2 antigens; peptide

Indexed keywords

CD8 ANTIGEN; H2 ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; DISEASE CONTROL; GRAFT VERSUS HOST REACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNIZATION; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOBLAST;

EID: 0029910762     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118832     Document Type: Article

References (39)

1. Rammensee, H.G., K. Falk, and O. Rötzschke. 1993. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11:213-244.
2. Rudensky, A.Y., P. Preston-Hulburt, S.C. Hong, A. Barlow, and C.A. Janeway. 1991. Sequence analysis of peptides hound to MHC class II molecules. Nature (Lond.). 353:622-627.
3. Ashton-Rickardt, P.G., L. van Kaer, T.N.M. Schumacher, H.L. Ploegh, and S. Tonegawa. 1994. Evidence for a differential avidity model ol T cell selection in the thymus. Cell. 76:651-663.
4. Correa, I., and D.H. Raulet. 1995. Binding of diverse peptides to MHC class I molecules inhibits cell lysis by activated natural killer cells. Immunity. 2: 61-71.
5. Malnati, M.S., M. Peruzzi, K.C. Parker, W.E. Biddison, E. Ciccone, E. Moretta, and E. Long. 1995. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science (Wash. DC). 267:1016-1018.
6. Sebzda, E., V.A. Wallace, J. Mayer, R.S.M. Yeung, T.W. Mak, and P.S. Ohashi. 1994. Positive and negative selection induced by different concentrations of a single peptide. Science (Wash. DC). 263:1615-1618.
7. Wallny, H.J., and H.G. Rammensee. 1990. Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature (Lond.). 343:275-278.
8. Perreault, C. F. Décary, S. Brochu, M. Gyger, R. Bélanger, and D.C. Roy. 1990. Minor histocompatibility antigens. Blood. 76:1269-1280.
9. Loveland, B., and E. Simpson. 1986. The non-MHC transplantation antigens:neither weak nor minor. Immunol. Today. 7:223-229.
10. Martin, P.J. 1991. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors. Bone Marrow Transplant. 8:217-223.
11. Wettstein, P.J. 1986. Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. II Observation of a hierarchy among dominant antigens. Immunogenetics. 24:24-31.
12. Korngold, R., and P.J. Wettstein. 1990. Immunodominance in the graft-vs-host disease T cell response to minor histocompatibility antigens. J. Immunol. 145:4079-4088.
13. Brochu, S., C. Baron, F. Hétu, D.C. Roy, and C. Perreault. 1995. Oligoclonal expansion of cytotoxic T lymphocytes directed against a restricted number of minor histocompatibility antigens in hematopoietic chimeras. J. Immunol. 155:5104-5114.
14. Pion, S., P. Fontaine, C. Baron, M. Gyger, and C. Perreault. 1995. Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy. J. Clin. Invest. 95:1561-1568.
15. den Haan, J.M.M., N.E. Sherman, E. Blokland, E. Huczko, F. Koning, J.W. Drijfhout, J. Skipper, J. Shabanowitz, D.F. Hunt, J. Engelhard, and E. Goulmy. 1995. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science (Wash. DC). 268:1476-1480.
16. Wang, W., L.R. Meadows, J.M.M. den Haan, N.E. Sherman, Y. Chen, E. Blokland, J. Shabanowitz, A.I. Agulnik, R.C. Hendrickson, C.E. Bishop et al. 1995. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science (Wash. DC). 269:1588-1590.
17. Loveland, B., C.R. Wang, H. Yonekawa, E. Hermel, and K. Fischer Lindahl. 1990. Maternally transmitted histocompatibility antigen of mice:a hydrophobic peptide of a mitochondrially encoded protein. Cell. 60:971-980.
18. Scott, D.M., I.E., Ehrmann, P.S. Ellis, C.E. Bishop, A.I. Agulnik, E. Simpson, and M.J. Mitchell. 1995. Identification of a mouse male-specific transplantation antigen. H-Y. Nature (Lond.). 376:695-698.
19. Morse, M.C., G. Bleau, V.M. Dabhi, F. Hétu, E.A. Drobetsky, K. Fischer Lindahl, and C. Perreault. 1996. The COI mitochondrial gene encodes a minor histocompatibility antigen presented by H2-M3. J. Immunol. 156:3301-3307.
20. Wei, M.L., and P.J. Cresswell. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Naure (Lond.). 356:443-446.
21. Storkus, W.J., H.J. Zeh, R.D. Salter, and M.T. Lotze. 1993. Identification of T-cell epitopes:rapid isolation of class I-presented peptides from viable cells by mild acid elution. J. Immunother. 14:94-103.
22. Fontaine, P., J. Langlais, and C. Perreault. 1991. Evaluation of in vitro cytotoxic T lymphocyte assays as a predictive test for the occurrence of graft vs host disease. Immunogenetics. 34:222-226.
23. Yin, L., G. Poirier, O. Neth, J.J. Hswan, N.F. Totty, and H.J. Stauss. 1993. Few peptides dominate cytotoxic T lymphocyte responses to single and multiple minor histocompatibility antigens. Int. Immunol. 5:1003-1007.
24. Franksson, L., M. Petersson, R. Kiessling, and K. Kärre. 1993. Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells. Eur. J. Immunol. 23: 2606-2613.
25. Rammensee, H.G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics. 41:178-228.
26. Feltkamp, M.C.W., G.R. Vreugdenhil, M.P.M. Vierboom, E. Ras, S.H. van der Burg, J.T. Schegget, C.J.M. Melief, and W.M. Kast. 1995, Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors. Eur. J. Immunol. 25:2638-2642.
27. Chen, W., S. Khilko, J. Fecondo, D.H. Margulies, and J. McCluskey. 1994 Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J. Exp. Med. 180:1471-1483.
28. Burke, T.W.L., C.T. Mant, and R.S. Hodges. 1991. The effect of varying flow-rate, gradient-rate, and detection wavelength on peptide elution profiles in reversed-phase chromatography. In High Performance Liquid Chromatography of Peptides and Proteins: Separation, Analysis, and Conformation, C.T. Mant, and R.S. Hodges, editors. CRC Press, Inc., Boca Raton, Florida. 307-317.
29. b at 2.4 A resolution: implications for antigen-determinant selection. Cell. 76:39-50.
30. Jorgensen, J.L., U. Esser, B. Fazekas de St. Groth, P.A. Reay, and M.M. Davis. 1992. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature (Lond.). 355:224-230.
31. Dyall, R., L.V. Vasovic, A. Molano, and J. Nikolic-Zugic. 1995. CD4-independent in vivo priming of murine CTL by optimal MHC class I-restricted peptides derived from intracellular pathogens. Int. Immunol. 7:1205-1212.
32. Takeshita, T., H. Takahashi, S. Kozlowski, J.D. Ahlers, C.D. Pendleton, R.L. Moore, Y. Nakagawa, K. Yokomuro, B.S. Fox, D.H. Margulies, and J.A. Berzofsky. 1995. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II molecule. J. Immunol. 154:1973-1986.
33. Ferrara, J.L.M., and H.J. Deeg. 1991. Mechanisms of disease: graft-versus-host disease. New Engl. J. Med. 324:667-674.
34. Korngold, R. 1991. Pathophysiology of graft-versus-host disease directed to minor histocompatibility antigens. Bone Marrow Transplant. 7(Suppl. 1):38-41.
35. van Els, C.A.C.M., A. Bakker, A.H. Zwinderman, F.E. Zwaan, J.J. van Rood, and E. Goulmy. 1990. Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. I. Absence of correlation with cytotoxic effector cells. Transplantation. 50:62-66.
36. Goulmy, E., R. Schipper, J. Pool, E. Blokland, J.H.F. Falkenburg, J. Vossen, A. Gratwohl, G.B. Vogelsang, H.C. van Houwelingen, and J.J. van Rood. 1996. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N. Engl. J. Med. 334:281-285.
37. Miconnet, I., V. De La Selle, C. Tucek, R. Huchet, D. Bonardelle, and M. Bruley-Rosset. 1994. Tissue distribution and polymorphism of minor histocompatibility antigens involved in GVHR. Immunogenetics. 39:178-186.
38. Aichele, P., K. Brduscha-Riem, R.M. Zinkernagel, H. Hengartner, and H. Pircher. 1995. T cell priming versus T cell tolerance induced by synthetic peptides. J. Exp. Med. 182:261-266.
39. + cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism? J. Exp. Med. 183:879-889.